US EditionFDA Approves Leucovorin as Autism Treatment
The FDA approved GlaxoSmithKline's leucovorin with a label update for autism-related symptoms; state Medicaid programs will cover the drug, affecting many children with neurological markers.
12 Articles
12 Articles
FDA approves drug that Trump due to suggest as autism treatment
The U.S. Food and Drug Administration announced approval of leucovorin, a form of folic acid that U.S. President Donald Trump was slated to suggest as a treatment for autism symptoms at a White House event on Monday.
Monday, the U.S. Food and Medical Administration (FDA) published an announcement in the Federal Register before the US President Donald Trump's speech, approving a version of GlaxoSmithKline (GSK), which the pharmaceutical company...
Washington, Sep 22 (EFE).- The U.S. Food and Drug Administration (FDA) announced Monday the approval of leucovorin as a treatment for autistic and brain-deficient folate children. According to the FDA, this generic drug used to treat patients with cancer or anemia, among others, can help children with autism improve their verbal communication. “One study found that, in children with autism and chronic folate deficiency, two thirds of children wi…
Coverage Details
Bias Distribution
- 70% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
